Brief: Aap Implantate To Discontinue Parts Of Its Standard Trauma Business
09/07/2019 07:13
July 9 (Reuters) - Aap Implantate AG AAQG.DE :
* DGAP-NEWS: AAP WILL DISCONTINUE PARTS OF ITS STANDARD
TRAUMA
BUSINESS AT THE END OF FY/2019 WITHIN A COST REDUCTION AND
EFFICIENCY ENHANCEMENT PROGRAM
* IN FUTURE, COMPANY AIMS TO FOCUS ON LOQTEQ(R), SILVER
COATING,
RESORBABLE MAGNESIUM IMPLANTS AND CANNULATED SCREWS
Source text for Eikon: ID:nEQ1cCMWNa
Further company coverage: AAQG.DE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on aap Implantate AG
See all newsBrief: Aap Confirms Rubino Di Girolamo As CEO Through The End Of 2028 COO Agnieszka Mierzejewska Will Leave The Company At The End Of The Year
Brief: aap Implantate Says Postponement Of Publication Of Annual Financial Statements
Brief: Aap Implantate AG Says Increases Its EBITDA In 9M From - 1.6 Mln Euros To 0 Euros
Brief: aap Implantate Says Resumes Step-By-Step Restart Of It Systems
Brief: Aap Implantate Says Possible Cyber Attack On Co